HITI
High TideDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade D from latest DB weights. Momentum 15.9 / Value 64.7
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
16
Value
65
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $5.15
Why
Momentum16 · Δ7d -
Value65 · Δ7d -0.2
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
16
40% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
65
60% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
+0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 15.9 / Value 64.7
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$197.68M
Beta
1.19
Shares Out
87.87M
P/E (TTM) · Derived
-5.1
P/S (TTM)
0.59
P/FCF (TTM)
17.03
Rev YoY
+35.0%
EPS YoY
-93.7%
Gross Margin
+9.9%
Op Margin
-0.4%
Net Debt
$44.17M
Current Ratio
1.46
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology